Document Detail


Mechanisms involved in increased sensitivity to adenosine A2A receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries.
MedLine Citation:
PMID:  24309216     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hypoxia-induced coronary vasorelaxation is a compensatory mechanism increasing blood flow. We hypothesized that hypoxia shares pathways with adenosine and causes vasorelaxation through the adenosine A2A receptor and force suppression by increasing cAMP and phosphorylated heat shock protein (HSP)20. Adenosine receptors in porcine left anterior descending coronary arteries (LAD) were examined by RT-PCR and isometric tension recording in myographs. Vasorelaxation was induced by adenosine, 1% oxygen, or both in the absence or presence of ZM241385, an adenosine A2A receptor antagonist. cAMP was determined by ELISA and p-HSP20/HSP20 and p-MLC/MLC were determined by immunoblotting and densitometric analyses. In coronary arteries exposed to 1% oxygen, there was increased sensitivity to adenosine, the adenosine A2 selective agonist NECA, and the adenosine A2A selective receptor agonist CGS21680. ZM241385 shifted concentration-response curves for CGS21680 to the right, whereas the adenosine A1 antagonist DPCPX, the adenosine A2B receptor antagonist MRS1754 and the adenosine A3 receptor antagonist MRS1523 failed to reduce vasodilatation induced by CGS21680. 1% oxygen or adenosine increased cAMP accumulation and HSP20 phosphorylation without changing T850-MYPT1 and MLC phosphorylation. ZM241385 failed to change 1% oxygen-induced vasodilation, cAMP accumulation, HSP20 phosphorylation and MLC phosphorylation. The PKA inhibitor Rp-8-CPT-cAMPS significantly reduced vasorelaxation induced by 1% oxygen or CGS21680. Our findings suggest that the increased sensitivity to adenosine, NECA, and CGS21680 at 1% oxygen involves adenosine A2A receptors. Adenosine and 1% oxygen induce vasorelaxation in PGF2α-contracted porcine coronary arteries partly by force suppression caused by increased cAMP and phosphorylation of HSP20.
Authors:
Elise R Hedegaard; Berit D Nielsen; Susie Mogensen; Christopher M Rembold; Ole Frøbert; Ulf Simonsen
Related Documents :
11884206 - Colocalization of vasopressin and oxytocin in hypothalamic magnocellular neurons in wat...
17133186 - Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
25127356 - The role of p450 metabolism in the estrogenic activity of bifenthrin in fish.
10561596 - Structural requirements for v2 vasopressin receptor proteolytic cleavage.
11559776 - Bicarbonate and fluid secretion evoked by cholecystokinin, bombesin and acetylcholine i...
17964136 - Regulation of notch signaling by glycosylation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-2
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Published by Elsevier B.V.
Affiliation:
Department of Biomedicine, Pulmonary and Cardiovascular Pharmacology, MEMBRANES, University of Aarhus, Denmark. Electronic address: erh@farm.au.dk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitative imaging biomarkers for the evaluation of cardiovascular complications in type 2 diabete...
Next Document:  The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity acco...